Identification of Potent CDK9 Inhibitors with Novel Skeletons via Virtual Screening, Biological Evaluation, and Molecular Dynamics Simulation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of Potent CDK9 Inhibitors with Novel Skeletons via Virtual Screening, Biological Evaluation, and Molecular Dynamics Simulation

Published:2024-09-08 Issue: Volume: Page:
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Yang Qiannan¹²,Shen Zheyuan¹,Chen Roufen¹,Yao Chenpeng¹,Pan Zhichao¹,Wu Depei²,Dong Xiaowu¹^ORCID

Affiliation:

1. Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China

2. Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou 215005, P. R. China

Funder

lCE Bio-science Inc.

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.4c00337

Reference43 articles.

1. NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021

2. Emerging agents and regimens for AML

3. Cyclin dependent kinase (CDK) inhibitors as anticancer drugs

4. Cdks, cyclins and CKIs: roles beyond cell cycle regulation

5. CDK9 inhibitors in acute myeloid leukemia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP